{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:15:32Z","timestamp":1759342532187,"version":"3.44.0"},"reference-count":40,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2018,11,10]]},"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:p>Although idiopathic hypereosinophilic syndrome (HES) is uncommon, we studied the clinical characteristics of this disorder in patients with cutaneous involvement. We chronicle the case of a patient with diffuse skin rash due to idiopathic HES from our clinical experience. Furthermore, a systematic literature search of the medical databases PubMed and Google Scholar was conducted. A total of 32 cases fulfilled the inclusion criteria. The data on patients\u2019 characteristics, epidemiology, clinical features, diagnosis, treatment and outcome were collected and analysed. This review illustrates that physicians should maintain a high index of clinical suspicion for idiopathic HES in patients presenting with dermatological lesions and hypereosinophilia, without an obvious cause. Randomised clinical trials are warranted to outline a generalised and efficient therapeutic approach in these patients. Additionally, this paper highlights the need for population-based studies to delineate the magnitude and scope of this association.<\/jats:p>","DOI":"10.1136\/bcr-2018-227137","type":"journal-article","created":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T17:19:47Z","timestamp":1545153587000},"page":"bcr-2018-227137","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":12,"title":["Idiopathic hypereosinophilic syndrome with cutaneous involvement: a comparative review of 32 cases"],"prefix":"10.1136","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7576-7319","authenticated-orcid":false,"given":"Faisal","family":"Inayat","sequence":"first","affiliation":[{"name":"Allama Iqbal Medical College, Lahore, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacey S","family":"O\u2019Neill","sequence":"additional","affiliation":[{"name":"Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahad","family":"Zafar","sequence":"additional","affiliation":[{"name":"King Edward Medical University, Lahore, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sindhuja","family":"Marupudi","sequence":"additional","affiliation":[{"name":"Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izzah","family":"Vasim","sequence":"additional","affiliation":[{"name":"Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2018,12,3]]},"reference":[{"doi-asserted-by":"publisher","key":"2025082703373866000_11.1.bcr-2018-227137.1","DOI":"10.7326\/0003-4819-68-6-1220"},{"key":"2025082703373866000_11.1.bcr-2018-227137.2","first-page":"760","article-title":"Gastrointestinal and Hepatic Involvement in Hypereosinophilic Syndrome","volume":"8","author":"Inayat","year":"2016","journal-title":"Cureus"},{"doi-asserted-by":"publisher","key":"2025082703373866000_11.1.bcr-2018-227137.3","DOI":"10.1056\/NEJMoa070812"},{"key":"2025082703373866000_11.1.bcr-2018-227137.4","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/ajh.24196","article-title":"World Health Organization-defined eosinophilic disorders: 2015 update on diagnosis, risk stratification, and management","volume":"90","author":"Gotlib","year":"2015","journal-title":"Am J Hematol"},{"doi-asserted-by":"publisher","key":"2025082703373866000_11.1.bcr-2018-227137.5","DOI":"10.1136\/adc.62.6.601"},{"doi-asserted-by":"publisher","key":"2025082703373866000_11.1.bcr-2018-227137.6","DOI":"10.1046\/j.1365-2133.1997.19972078.x"},{"doi-asserted-by":"publisher","key":"2025082703373866000_11.1.bcr-2018-227137.7","DOI":"10.1111\/j.1365-2133.2000.03726.x"},{"key":"2025082703373866000_11.1.bcr-2018-227137.8","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1346-8138.2000.tb02131.x","article-title":"Complete remission of hypereosinophilic syndrome after interferon-alpha therapy: report of a case and literature review","volume":"27","author":"Yoon","year":"2000","journal-title":"J Dermatol"},{"doi-asserted-by":"publisher","key":"2025082703373866000_11.1.bcr-2018-227137.9","DOI":"10.1046\/j.1365-2133.2003.05309.x"},{"doi-asserted-by":"publisher","key":"2025082703373866000_11.1.bcr-2018-227137.10","DOI":"10.1016\/S0190-9622(03)00466-3"},{"key":"2025082703373866000_11.1.bcr-2018-227137.11","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1055\/s-2004-820544","article-title":"[Idiopathic hypereosinophilia with cardiac involvement]","volume":"129","author":"Martin","year":"2004","journal-title":"Dtsch Med Wochenschr"},{"doi-asserted-by":"publisher","key":"2025082703373866000_11.1.bcr-2018-227137.12","DOI":"10.1097\/01.rhu.0000147147.72878.55"},{"doi-asserted-by":"publisher","key":"2025082703373866000_11.1.bcr-2018-227137.13","DOI":"10.1016\/j.jpeds.2004.09.014"},{"key":"2025082703373866000_11.1.bcr-2018-227137.14","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1346-8138.2005.tb00764.x","article-title":"A case of hypereosinophilic syndrome","volume":"32","author":"Amano","year":"2005","journal-title":"J Dermatol"},{"doi-asserted-by":"publisher","key":"2025082703373866000_11.1.bcr-2018-227137.15","DOI":"10.1001\/archderm.142.12.1606"},{"key":"2025082703373866000_11.1.bcr-2018-227137.16","first-page":"801","article-title":"Cardiogenic shock with hypereosinophilic syndrome","volume":"46","author":"Prasad","year":"2009","journal-title":"Indian Pediatr"},{"key":"2025082703373866000_11.1.bcr-2018-227137.17","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1440-0960.2009.00610.x","article-title":"Isolated symptomatic cutaneous disease in hypereosinophilic syndrome","volume":"51","author":"Preda","year":"2010","journal-title":"Australas J Dermatol"},{"key":"2025082703373866000_11.1.bcr-2018-227137.18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4103\/0019-5154.77570","article-title":"Hypereosinophilic syndrome: cutaneous involvement as the sole manifestation","volume":"56","author":"Sundaramurthi","year":"2011","journal-title":"Indian J Dermatol"},{"key":"2025082703373866000_11.1.bcr-2018-227137.19","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2340\/00015555-1044","article-title":"Extensive digital gangrene without evidence of large-vessel occlusion in hypereosinophilic syndrome","volume":"91","author":"Kim","year":"2011","journal-title":"Acta Derm Venereol"},{"key":"2025082703373866000_11.1.bcr-2018-227137.20","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/ICB.0b013e318228e32b","article-title":"Purtscher-like retinopathy and primary hypereosinophilic syndrome association","volume":"6","author":"Howard","year":"2012","journal-title":"Retin Cases Brief Rep"},{"key":"2025082703373866000_11.1.bcr-2018-227137.21","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2230.2012.04370.x","article-title":"Persistent hypereosinophilia with Wells syndrome","volume":"38","author":"Powell","year":"2013","journal-title":"Clin Exp Dermatol"},{"unstructured":"Carlsen BC , Heidenheim M . A case of hypereosinophilic syndrome with cutaneous lesions as presenting sign. J Clin Exp Dermatol Res S;6:009.","key":"2025082703373866000_11.1.bcr-2018-227137.22"},{"key":"2025082703373866000_11.1.bcr-2018-227137.23","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/j.athoracsur.2013.12.078","article-title":"Pneumothorax as the initial manifestation of idiopathic hypereosinophilic syndrome","volume":"98","author":"Wang","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"2025082703373866000_11.1.bcr-2018-227137.24","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3315\/jdcr.2014.1185","article-title":"Idiopathic hypereosinophilic syndrome: a rare cause of erythroderma","volume":"8","author":"Mahajan","year":"2014","journal-title":"J Dermatol Case Rep"},{"key":"2025082703373866000_11.1.bcr-2018-227137.25","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1097\/DAD.0000000000000279","article-title":"Idiopathic hypereosinophilic syndrome with cutaneous manifestations and flame figures: A spectrum of eosinophilic dermatoses whose features overlap with wells\u2019 syndrome","volume":"37","author":"Smith","year":"2015","journal-title":"Am J Dermatopathol"},{"key":"2025082703373866000_11.1.bcr-2018-227137.26","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/ced.12709","article-title":"Hypereosinophilic syndrome: an indolent rash with a serious cardiac complication","volume":"41","author":"Merika","year":"2016","journal-title":"Clin Exp Dermatol"},{"key":"2025082703373866000_11.1.bcr-2018-227137.27","doi-asserted-by":"crossref","first-page":"328","DOI":"10.12998\/wjcc.v4.i10.328","article-title":"Idiopathic hypereosinophilic syndrome presenting with severe vasculitis successfully treated with imatinib","volume":"4","author":"Fraticelli","year":"2016","journal-title":"World J Clin Cases"},{"key":"2025082703373866000_11.1.bcr-2018-227137.28","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/MPH.0000000000000668","article-title":"Hypereosinophilic Syndrome: Hacettepe Experience","volume":"38","author":"Tavil","year":"2016","journal-title":"J Pediatr Hematol Oncol"},{"key":"2025082703373866000_11.1.bcr-2018-227137.29","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jid.2016.10.044","article-title":"Treatment of hypereosinophilic syndrome with cutaneous involvement with the jak inhibitors tofacitinib and ruxolitinib","volume":"137","author":"King","year":"2017","journal-title":"J Invest Dermatol"},{"doi-asserted-by":"publisher","key":"2025082703373866000_11.1.bcr-2018-227137.30","DOI":"10.1053\/j.seminhematol.2012.01.006"},{"key":"2025082703373866000_11.1.bcr-2018-227137.31","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s12016-015-8506-7","volume":"50","author":"Curtis","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"doi-asserted-by":"publisher","key":"2025082703373866000_11.1.bcr-2018-227137.32","DOI":"10.1016\/j.iac.2007.07.009"},{"doi-asserted-by":"publisher","key":"2025082703373866000_11.1.bcr-2018-227137.33","DOI":"10.4065\/mcp.2009.0503"},{"key":"2025082703373866000_11.1.bcr-2018-227137.34","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11882-012-0241-z","article-title":"Clinical overview of cutaneous features in hypereosinophilic syndrome","volume":"12","author":"Pl\u00f6tz","year":"2012","journal-title":"Curr Allergy Asthma Rep"},{"doi-asserted-by":"publisher","key":"2025082703373866000_11.1.bcr-2018-227137.35","DOI":"10.1111\/bjh.12729"},{"key":"2025082703373866000_11.1.bcr-2018-227137.36","doi-asserted-by":"crossref","first-page":"e210","DOI":"10.1016\/j.jaad.2012.02.043","article-title":"Narrowband UVB therapy for the treatment of pruritus in hypereosinophilic syndrome: clinical report and review of the literature on phototherapy","volume":"67","author":"Gattringer","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"2025082703373866000_11.1.bcr-2018-227137.37","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/jocs.12483","article-title":"Tricuspid valve surgery in patients with idiopathic hypereosinophilic syndrome","volume":"30","author":"Besik","year":"2015","journal-title":"J Card Surg"},{"doi-asserted-by":"publisher","key":"2025082703373866000_11.1.bcr-2018-227137.38","DOI":"10.1136\/heartjnl-2015-307959"},{"doi-asserted-by":"publisher","key":"2025082703373866000_11.1.bcr-2018-227137.39","DOI":"10.1182\/blood-2003-01-0006"},{"key":"2025082703373866000_11.1.bcr-2018-227137.40","first-page":"289","article-title":"Eosinophilia and Hypereosinophilic Disorders - Update on Etiopathogeny, Classification and Clinical Approach","volume":"53","author":"Leru","year":"2015","journal-title":"Rom J Intern Med"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bcr-2018-227137","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2018-227137","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T10:37:53Z","timestamp":1756291073000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2018-227137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12,3]]},"published-print":{"date-parts":[[2018,11]]}},"alternative-id":["10.1136\/bcr-2018-227137"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2018-227137","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2018,11]]}}}